Clinical stage biotechnology company focused on treating infectious diseases using recombinant nanoparticle vaccine technology
Gregory Glenn, MD
President of Research and Development
https://www.linkedin.com/in/greg-glenn-81705533/
COVID-19 Vaccine Development Update: An Interview With Novavax
Molly Campbell
https://www.technologynetworks.com/biopharma/blog/covid-19-vaccine-development-update-an-interview-with-novavax-332634?fbclid=IwAR3IqUNxC6CqL8L-EPAjogqkxFuTo4A-hXhZszx-GrZaLebRJE--tZ3lPOQ
Web
March 26, 2020